Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. Abstract Text:

    giovanni c actisGiovanni C Actis,rinaldo pellicanoRinaldo Pellicano,marco pinna-pintorMarco Pinna-Pintor,mario rizzettoMario Rizzetto,

    BACKGROUND: Total proctocolectomy and ileal pouch anal anastomosis (IPAA) is the preferred operation for patients with chronic ulcerative colitis (CUC) refractory to medical therapy. Infliximab (IFX), an antitumor necrosis factor-alpha antibody, has demonstrated efficacy in medical management of CUC. The aim of this study is to determine if IFX before IPAA impacts short-term outcomes. STUDY DESIGN: A prospective institutional database was retrospectively reviewed for short-term complications after IPAA for CUC. Postoperative outcomes were compared between patients who received pre-IPAA IFX and those who did not. RESULTS: Between 2002 and 2005, 47 patients received IFX before IPAA, and 254 patients received none. There were no gender (p = 0.16) or body mass index (p = 0.07) differences between groups. IFX patients were younger than non-IFX patients (mean age 28.1 to 39.3 years) (p < 0.001). In IFX patients, 70% were receiving preoperative IFX, azathioprine, and corticosteroids. Mortality was nil. Overall surgical morbidity was similar: 61.7% and 48.8%, IFX and non-IFX, respectively (p = 0.10). Anastomotic leaks (p = 0.02), pouch-specific (p = 0.01) and infectious (p < 0.01) complications were more common in IFX patients. Multivariable analysis revealed IFX as the only factor independently associated with infectious complications (odds ratio [OR] = 3.5; CI, 1.6-7.5). In a separate analysis, incorporating age, high-dose corticosteroids, azathioprine, and severity of colitis, IFX remained significantly associated with infectious complications (OR = 2.7; CI, 1.1-6.7). CONCLUSIONS: CUC patients treated with IFX before IPAA have substantially increased the odds of postoperative pouch-related and infectious complications. Additional prospective studies are required to determine if IFX alone or other factors contribute to the observed increases in infectious complications.

    Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. Publishing Authors By Initials

    gc actisGC Actis,r pellicanoR Pellicano,m pinna-pintorM Pinna-Pintor,m rizzettoM Rizzetto,

    For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of the American College of Surgeons

    VOLUME: 204

    Page Numbers: 956-62; discussion 962-3

    Journal Abbreviation:

    ISSN: 1072-7515

    DAY: 26

    MONTH: May

    YEAR: 2007

    Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9431305

    Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. Keywords Mesh Terms:

    KEYWORDS: Treatment Outcome

    MESH TERMS: drug therapy

    Chemical & Substance for Abstract: Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. Information

    Substance Name: infliximab

    Registry Number: 0

    Grant and Affiliation Information for Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

    AFFILIATION: Division of Colon and Rectal Surgery, Mayo Clinic, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Am Coll Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News